CSI Market
Sign In | Register

Glucotrack Inc (GCTK) Annual Income Statement

Annual · GAAP · USD millions
Access GCTK quarterly income statements →
The data below summarizes Glucotrack Inc's income statement results from Dec 31 2021 to Dec 31 2025, enabling period-by-period comparison of operating performance.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
2025 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Revenues
Total Revenue0.00
Costs & Expenses
Gross Profit0.00
Selling, Administration, Marketing6.28
Research and Development Expense9.81
(Gain) Loss Related to Litigation Settlement0.00
Other Operating Expense / -Income-32.18
Total operating costs including COS-16.09
Operating income / -loss16.09
Net Interest (-)Expense / Income0.00
Other loss / -income-3.30
Total costs & expenses-19.39
Income & Taxes
Income / -loss before income taxes19.39
Income after income taxes19.39
Income / -loss from continuing operations19.39
Net income / -loss19.39
Income / -loss to shareholder-19.39
EBIT19.39
EBITD19.43
EBITDA19.44
Earnings Per Share
Basic EPS (excl. extra items)468.30
Basic Net EPS468.30
Basic shares outstanding (Mill. of Units)0.04
Diluted Net EPS468.30
Diluted average shares (Mill. of Units)0.04
4 historic quarters locked

Sign in to unlock the full Glucotrack Inc income statement history.

Sign In Create Free Account

About Glucotrack Inc Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: March 30, 2026
  • Original filing: form10-k.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.